α7 Nicotinic Receptor Agonists: Potential Therapeutic Drugs for Treatment of Cognitive Impairments in Schizophrenia and Alzheimer's Disease
Accumulating evidence suggests that α7 nicotinic receptors (α7 nAChRs), a subtype of nAChRs, play a role in the pathophysiology of neuropsychiatric diseases, including schizophrenia and Alzheimer's disease (AD). A number of psychopharmacological and genetic studies shown that α7 nAChRs play an...
Saved in:
Published in | The open medicinal chemistry journal Vol. 4; pp. 37 - 56 |
---|---|
Main Authors | , |
Format | Journal Article |
Language | English |
Published |
United Arab Emirates
Bentham Open
27.05.2010
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Accumulating evidence suggests that α7 nicotinic receptors (α7 nAChRs), a subtype of nAChRs, play a role in the pathophysiology of neuropsychiatric diseases, including schizophrenia and Alzheimer's disease (AD). A number of psychopharmacological and genetic studies shown that α7 nAChRs play an important role in the deficits of P50 auditory evoked potential in patients with schizophrenia, and that (α nAChR agonists would be potential therapeutic drugs for cognitive impairments associated with P50 deficits in schizophrenia. Furthermore, some studies have demonstrated that α7 nAChRs might play a key role in the amyloid-β (Aβ)-mediated pathology of AD, and that α7 nAChR agonists would be potential therapeutic drugs for Aβ deposition in the brains of patients with AD. Interestingly, the altered expression of α7 nAChRs in the postmortem brain tissues from patients with schizophrenia and AD has been reported. Based on all these findings, selective α7 nAChR agonists can be considered potential therapeutic drugs for cognitive impairments in both schizophrenia and AD. In this article, we review the recent research into the role of α7 nAChRs in the pathophysiology of these diseases and into the potential use of novel α7 nAChR agonists as therapeutic drugs. |
---|---|
AbstractList | Accumulating evidence suggests that α7 nicotinic receptors (α7 nAChRs), a subtype of nAChRs, play a role in the pathophysiology of neuropsychiatric diseases, including schizophrenia and Alzheimer's disease (AD). A number of psychopharmacological and genetic studies shown that α7 nAChRs play an important role in the deficits of P50 auditory evoked potential in patients with schizophrenia, and that (α nAChR agonists would be potential therapeutic drugs for cognitive impairments associated with P50 deficits in schizophrenia. Furthermore, some studies have demonstrated that α7 nAChRs might play a key role in the amyloid-β (Aβ)-mediated pathology of AD, and that α7 nAChR agonists would be potential therapeutic drugs for Aβ deposition in the brains of patients with AD. Interestingly, the altered expression of α7 nAChRs in the postmortem brain tissues from patients with schizophrenia and AD has been reported. Based on all these findings, selective α7 nAChR agonists can be considered potential therapeutic drugs for cognitive impairments in both schizophrenia and AD. In this article, we review the recent research into the role of α7 nAChRs in the pathophysiology of these diseases and into the potential use of novel α7 nAChR agonists as therapeutic drugs. |
Author | Toyohara, Jun Hashimoto, Kenji |
AuthorAffiliation | Division of Clinical Neuroscience, Chiba University Center for Forensic Mental Health, Chiba, Japan |
AuthorAffiliation_xml | – name: Division of Clinical Neuroscience, Chiba University Center for Forensic Mental Health, Chiba, Japan |
Author_xml | – sequence: 1 givenname: Jun surname: Toyohara fullname: Toyohara, Jun organization: Division of Clinical Neuroscience, Chiba University Center for Forensic Mental Health, Chiba, Japan – sequence: 2 givenname: Kenji surname: Hashimoto fullname: Hashimoto, Kenji |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/21249164$$D View this record in MEDLINE/PubMed |
BookMark | eNptUctu1TAQtVARfcAXICHvurqtHT_DAunqlj6kChBc1pbjTG6MEjvYSaX2G_gZfoRvaqKWqkhsZkZnzpyZ0TlEeyEGQOgtJScFVfyUasUp4YJQQvgSmHqBDhZ0tcB7z-p9dJjzD0Ik01y9QvsFLXhJJT9Av_78VviTd3H0wTv8FRwMY0x4vYvB5zG_x1_iCGH0tsPbFpIdYBpn4lmadhk3M3ObwI79TMGxwZu4C370N4Cv-sH6tOAZ-4C_udbfxaFNELzFNtR43d214HtIxxmf-Qw2w2v0srFdhjeP-Qh9P_-43Vyurj9fXG3W1yvHtFArWhVlBVVhudDESg7zU0LUIJScAWhKW0hR16JyNefClaUSstJWas14TZRiR-jDg-4wVT3Ubj4y2c4Myfc23Zpovfm3E3xrdvHGMFIwIsUscPwokOLPCfJoep8ddJ0NEKdsNJe6lEosq9gD06WYc4LmaQslZrHR_MfGeerd8wOfZv76xu4BrLedHw |
CitedBy_id | crossref_primary_10_2174_1389450121666200615150429 crossref_primary_10_3389_fnins_2023_1179611 crossref_primary_10_9758_cpn_2011_9_3_111 crossref_primary_10_3390_ijms23073463 crossref_primary_10_1021_jacs_2c04064 crossref_primary_10_3389_fphar_2019_00073 crossref_primary_10_1021_acschemneuro_8b00450 |
ContentType | Journal Article |
Copyright | Toyohara and Hashimoto; Licensee . 2010 Toyohara and Hashimoto |
Copyright_xml | – notice: Toyohara and Hashimoto; Licensee . 2010 Toyohara and Hashimoto |
DBID | NPM AAYXX CITATION 7X8 5PM |
DOI | 10.2174/1874104501004010037 |
DatabaseName | PubMed CrossRef MEDLINE - Academic PubMed Central (Full Participant titles) |
DatabaseTitle | PubMed CrossRef MEDLINE - Academic |
DatabaseTitleList | PubMed |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Chemistry |
EISSN | 1874-1045 |
EndPage | 56 |
ExternalDocumentID | 10_2174_1874104501004010037 21249164 |
Genre | Journal Article |
GroupedDBID | --- 123 29N 2WC 53G ADBBV ADRAZ ALMA_UNASSIGNED_HOLDINGS AOIJS BAWUL CS3 DIK E3Z EBS EJD GX1 HH5 HYE JBO KQ8 M48 M~E NPM O-Q O5R O5S OK1 PGMZT RPM TR2 AAYXX CITATION 7X8 5PM |
ID | FETCH-LOGICAL-c3857-1b29beb2a4580a64e84755de576580ef9a265dd5bcd445c99756b8a68834d0773 |
IEDL.DBID | RPM |
ISSN | 1874-1045 |
IngestDate | Tue Sep 17 21:19:59 EDT 2024 Sat Aug 17 02:01:23 EDT 2024 Fri Aug 23 01:30:14 EDT 2024 Tue Aug 27 13:49:52 EDT 2024 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Keywords | Schizophrenia Cognition Alzheimer’s disease α7 Nicotinic receptors |
Language | English |
License | This is an open access article licensed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c3857-1b29beb2a4580a64e84755de576580ef9a265dd5bcd445c99756b8a68834d0773 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
OpenAccessLink | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3023065/ |
PMID | 21249164 |
PQID | 846896757 |
PQPubID | 23479 |
PageCount | 20 |
ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_3023065 proquest_miscellaneous_846896757 crossref_primary_10_2174_1874104501004010037 pubmed_primary_21249164 |
PublicationCentury | 2000 |
PublicationDate | 20100527 |
PublicationDateYYYYMMDD | 2010-05-27 |
PublicationDate_xml | – month: 5 year: 2010 text: 20100527 day: 27 |
PublicationDecade | 2010 |
PublicationPlace | United Arab Emirates |
PublicationPlace_xml | – name: United Arab Emirates |
PublicationTitle | The open medicinal chemistry journal |
PublicationTitleAlternate | Open Med Chem J |
PublicationYear | 2010 |
Publisher | Bentham Open |
Publisher_xml | – name: Bentham Open |
SSID | ssj0063847 |
Score | 2.2203372 |
Snippet | Accumulating evidence suggests that α7 nicotinic receptors (α7 nAChRs), a subtype of nAChRs, play a role in the pathophysiology of neuropsychiatric diseases,... |
SourceID | pubmedcentral proquest crossref pubmed |
SourceType | Open Access Repository Aggregation Database Index Database |
StartPage | 37 |
SummonAdditionalLinks | – databaseName: Scholars Portal Journals: Open Access dbid: M48 link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3NbtQwELZKOZQLolBg-dMcOBJI1-PYQUJotW1VkIqQ2JV6i-x4tl2pJCXZlYATT8C9j9EX4SF4EsbJZum25cIlh8T2YWZif588840Qz4Mmlk5jH7nEUoSWKEpz3gyJjDTGTzDOQzXywYdkf4zvD9Xhmui6oi4MWF9L7UI_qXF18vLrl29v-Yd_E9KYGVC_Cm3lmFWoOKifhYfUN8TNPkoMIX-Ay2sFjjXUrfTQvyY24sBMSbYTXD2prsDPy1mUF46lvTvi9gJPwqANgE2xRsVdsTHs2rjdEz9_nWsI_p6FEkhgmEinzLNhcFQG0dz6NXwsZyFliFcZ_S3Ggp1qflQDQ1oYdbnoUE5g2KUbwTveSKZVUyEH0wI-XczeA1t4GJx8P6bpZ6p-_zirYae9CdoS473d0XA_WjRhiHIZZKK2XT91TL8tKhPbBIlNqJQn5in8giap7SfKe-Vyj6jyNNUqccYmxkj0sdbyvlgvyoIeCrBeT4jpoWKSh7HBVDqnCKVxMRmHcU-86AyenbZaGxlzlOCq7BpX9QR0TsnYpuGiwxZUzuuMMZVJmQnxkAetj5brdc7tCb3iveWAILe9-qWYHjey27Kha-rRf898LG51uQd9_USsz6o5PWVIM3PPmjD9A6rF920 priority: 102 providerName: Scholars Portal |
Title | α7 Nicotinic Receptor Agonists: Potential Therapeutic Drugs for Treatment of Cognitive Impairments in Schizophrenia and Alzheimer's Disease |
URI | https://www.ncbi.nlm.nih.gov/pubmed/21249164 https://search.proquest.com/docview/846896757 https://pubmed.ncbi.nlm.nih.gov/PMC3023065 |
Volume | 4 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3LbtQwFL3qdAMbxJvhUd0FS9JJx3bssBtNqQrSoEpMpe4iO77TRuoko3lsWPEF7PkMfoSP4Eu4TsalA6zYZJHYVuR7ZZ8jn3sM8Dp4Yuk89YnLLCXSEiV5yYshkRHG-JlMy1CNPPmYnZ7LDxfqYg9UrIVpRfulqw7r6_lhXV212srFvBxEndjgbDIWLXBWgx70tBCRonfLL-eT1J29UEDbg3DnHFMOlQZrtPAQujUAZtpxlMnd3egviPmnUvLW1nNyH-5tMSOOun97AHtUP4Q743hV2yP4-uO7xhDTdShzRIaCtGAujaPLJhjjrt7iWbMOsiAeZfq74AqPl5vLFTJsxWnUm2Mzw3GUFOF7XiyqZVsFh1WNn24r9NDWHkfXn6-omtPy55dvKzzuTnsew_nJu-n4NNletJCUIlhBHblh7phiW6lMajNJPIVKeWIuwi9oltthprxXrvRSqjLPtcqcsZkxQvpUa_EE9uumpmeA1usZMQVUTORkamQunFMkhXEpGSfTPryJE14sOj-NgnlICFXxj1D1AWNQCp7TcJhha2o2q4Jxk8mZ7XCTp12MbsaLwe2D3oneTYNgqb37hTOttdbeZtbz_-75Au5GfcFQv4T99XJDrxi2rN0B9CbSHLTJ-gsuqPC4 |
link.rule.ids | 230,315,733,786,790,891,24346,27957,27958,53827,53829 |
linkProvider | National Library of Medicine |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3NctMwEN4p5VAulH_SFtCBI07cWLJkbpmUTgpNpzOkTG8eydq0Hho7kziXnngC7jxGX4SH4Em6sqPSFC5w8cGyNbZ3JX3f-NtPAG-dJ5ZMQhuYWGPANWKQZDQZIqpIKTvmYeaqkYdH8eCEfzwVp2sgfC1MLdrPTN4uLibtIj-vtZXTSdbxOrHO8bAf1cBZdO7BfRqvXelJejMBU0Zx2RgMObzdcbvOEekQoTNHc4dI1hbARDx2Y766Hv0BMu9qJW8tPvub8MU_dqM5-dpeVKadXd5xdPzn93oED5dwlPWa5sewhsUT2Oj7XeCewvefV5K5dKlcBSUjlIlToumsd1Y6z935e3ZcVk5xRL2Mftdysb3Z4mzOCBGzkZeys3LM-l6txA5oHspndYEdywv2-bb4j-nCst7F5TnmE5z9-vZjzvaaH0nP4GT_w6g_CJZ7OARZ5Fymdk03McTeNRcq1DFHio0QFonm0AkcJ7obC2uFySznIksSKWKjdKxUxG0oZfQc1ouywJfAtJVjJHYpiCPyUPEkMkYgj5QJURketuCdj2Q6baw6UqI4LgfSv-RAC5iPdkrf1P0n0QWWi3lKkEwlRKTokhdN8G_681nTArmSFjcXOLfu1RYKdu3avQzu1n_f-QY2BqPhYXp4cPRpGx54GUNX7sB6NVvgK0JHlXldj4VrYN4R2A |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV27btswFCXaFGi79P1wn3foWFmKRYpkNsOukbRNYKAOEHQRSJFKhMaSYctLpn5B935GfiQfkS_ppWSmdtopiwaJIiTdS-oc8PBcQj44TywuIxPoRNmAKmsDmeFkaK2IhTA5jTK3G3n_INk9pJ-P2NFaqa9GtJ_polueTrtlcdJoK2fTLPQ6sXC8P4gb4MzCmcnD2-QOjtme9ES9nYQxqyhvTYYc5g5d5TkkHixyBmnuEPPGBhjJx3ZCN_9J_wDN63rJtR_Q6CH57h-91Z386C5r3c3Orrk63ujdHpEHK1gK_bbJY3LLlk_IvYGvBveU_Lo45-DSpnY7KQHRpp0hXYf-ceW8dxc7MK5qpzzCXiZ_93TBcL48XgAiY5h4STtUOQy8agn2cD4q5s1GOyhK-LYuAgRVGuifnp3YYmrnlz9_L2DYLig9I4ejT5PBbrCq5RBksXOb2tY9qZHFK8pEpBJqMT6MGYt0B0_YXKpewoxhOjOUskxKzhItVCJETE3EefycbJVVaV8SUIbnFlkmQ65II0FlrDWzNBY6skLTqEM--mims9ayI0Wq4_Ig_U8edAj4iKf4Td16iSpttVykCM2EREKFTV60CXDVn8-cDuEbqXHVwLl2b17BgDfu3asAv7rxne_J3fFwlH7dO_jymtz3aoYef0O26vnSvkWQVOt3zXD4A-MyFFg |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=%CE%B17+Nicotinic+Receptor+Agonists%3A+Potential+Therapeutic+Drugs+for+Treatment+of+Cognitive+Impairments+in+Schizophrenia+and+Alzheimer%E2%80%99s+Disease&rft.jtitle=The+open+medicinal+chemistry+journal&rft.au=Toyohara%2C+Jun&rft.au=Hashimoto%2C+Kenji&rft.date=2010-05-27&rft.pub=Bentham+Open&rft.eissn=1874-1045&rft.volume=4&rft.spage=37&rft.epage=56&rft_id=info:doi/10.2174%2F1874104501004010037&rft_id=info%3Apmid%2F21249164&rft.externalDBID=PMC3023065 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1874-1045&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1874-1045&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1874-1045&client=summon |